Su ZZ et al. first reported that BATF2 overexpression in malignant glioma, melanoma, and prostatic cancer cell lines strongly inhibited the growth and apoptosis of cancer cells, without harm to the survival of noncancerous cells [6]. The gene discussed is BATF2; the disease is prostate carcinoma.